An analysis of Methylenetetrahydrofolate reductase and Glutathione S-transferase omega-1 genes as modifiers of the cerebral response to ischemia

BMC Neurology

Volumn 9, Issue , 2009, Pages

  Peddareddygari, Leema Reddy ^a   Dutra, Ana Virginia ^a   Levenstien, Mark A ^b   Sen, Souvik ^c   Grewal, Raji P ^a  

^a NEW JERSEY NEUROSCIENCE INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE OMEGA 1; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); UNCLASSIFIED DRUG; GSTO1 PROTEIN, HUMAN;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CAUCASIAN; CEREBROVASCULAR ACCIDENT; DNA POLYMORPHISM; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; ALLELE; BLOOD; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ALLELES; BRAIN ISCHEMIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 68949217192     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-9-37     Document Type: Article

References (25)

1. Rosamond W Flagel K Friday G Furie K Go A Greenlund K Haase N Ho M Howard V Kissela B Kittner S Lloyd-Jones D McDermott M Meigs J Moy C Nichol G O'Donnell CJ Roger V Rumsfeld J Sorlie P Steinburger J Thom T Wasserthiel-Smoller S Hong Y American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 2007, 115(5):e69-171. 10.1161/CIRCULATIONAHA.106.179918 17194875
2. Goldstein LB Adams R Becker K Furberg CD Gorelick PB Hademenos G Hill M Howard G Howard VJ Jacobs B Levine SR Mosca L Sacco RL Sherman DG Wolf PA del Zoppo GJ Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association Stroke 2001, 32(1):280-99. 11136952
3. Dutra AV Lin HF Juo SH Boyadjis M Moussouttas M Reddy PL Grewal RP Analysis of the endothelial nitric oxide synthase gene as a modifier of the cerebral response to ischemia J Stroke Cerebrovasc Dis 2006, 15(3):128-31. 10.1016/j.jstrokecerebrovasdis.2006.03.002 17904064
4. Dutra AV Lin HF Juo SH Mohrenweiser H Sen S Grewal RP Analysis of the XRCC1 gene as a modifier of the cerebral response in ischemic stroke BMC Med Genet 2006, 7:78. 1654138 17087834 10.1186/1471-2350-7-78
5. Huang Z Huang PL Panahian N Dalkara T Fishman MC Moskowitz MA Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase Science 1994, 265:1883-1885. 10.1126/science.7522345 7522345
6. Harper AJ Production of transgenic and mutant mouse models Methods Mol Med 2005, 104:185-202. 15454668
7. Lovblad KO Baird AE Schlaug G Benfield A Siewert B Voetsch B et al Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome Ann Neurol 1997, 42(2):164-170. 10.1002/ana.410420206 9266725
8. Baird AE Dambrosia J Janket S Eichbaum Q Chaves C Silver B Barber PA Parsons M Darby D Davis S Caplan LR Edelman RE Warach S A three-item scale for the early prediction of stroke recovery Lancet 2001, 357(9274):2095-9. 10.1016/S0140-6736(00)05183-7 11445104
9. De Keyser J Sulter G Luiten PG Clinical trials with neuroprotective drugs in acute ischaemic stroke: Are we doing the right thing? Trends Neurosci 1999, 22(12):535-540. 10.1016/S0166-2236(99)01463-0 10542428
10. Morita-Fujimura Y Fujimura M Yoshimoto T Chan PH Superoxide during reperfusion contributes to caspase-8 expression and apoptosis after transient focal stroke Stroke 2001, 32(10):2356-61. 10.1161/ hs1001.097241 11588326
11. McCord JM Oxygen-derived free radicals in postischemic tissue injury N Engl J Med 1985, 312(3):159-63. 2981404
12. Liu PK DNA damage and repair in the brain after cerebral ischemia Curr Top Med Chem 2001, 1(6):483-95. 10.2174/1568026013394688 11895125
13. Sugawara T Chan PH Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia Antioxid Redox Signal 2003, 5(5):597-607. 10.1089/152308603770310266 14580316
14. Gursoy-Ozdemir Y Can A Dalkara T Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia Stroke 2004, 35(6):1449-53. 10.1161/01.STR.0000126044.83777.f4 15073398
15. Frosst P Blom HJ Milos R Goyette P Sheppard CA Matthews RG Boers GJ den Heijer M Kluijtmans LA Heuvel van den LP et al A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase Nat Genet 1995, 10(1):111-3. 10.1038/ ng0595-111 7647779
16. Kang SS Zhou J Wong PW Kowalisyn J Strokosch G Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase Am J Hum Genet 1988, 43(4):414-21. 1715503 3177384
17. Choi BO Kim NK Kim SH Kang MS Lee S Ahn JY Kim OJ Kim S Oh D Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions Thromb Res 2003, 111(1-2):39-44. 10.1016/j.thromres.2003.08.022 14644077
18. Sacco RL Anand K Lee HS Boden-Albala B Stabler S Allen R Paik MC Homocysteine and the risk of ischemic stroke in a triethnic cohort: The NOrthern MAnhattan Study Stroke 2004, 35(10):2263-9. 10.1161/ 01.STR.0000142374.33919.92 15345803
19. Endres M Ahmadi M Kruman I Biniszkiewicz D Meisel A Gertz K Folate deficiency increases postischemic brain injury Stroke 2005, 36(2):321-5. 10.1161/01.STR.0000153008.60517.ab 15625295
20. Dulhunty A Gage P Curtis S Chelvanayagam G Board P The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator J Biol Chem 2001, 276(5):3319-23. 10.1074/jbc.M007874200 11035031
21. Laliberte RE Perregaux DG Hoth LR Rosner PJ Jordan CK Peese KM Eggler JF Dombroski MA Geoghegan KF Gabel CA Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing J Biol Chem 2003, 278(19):16567-78. 10.1074/jbc.M211596200 12624100
22. Kolsch H Linnebank M Lutjohann D Jessen F Wullner U Harbrecht U Thelen KM Kreis M Hentschel F Schulz A von Bergmann K Maier W Heun R Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke Neurology 2004, 63(12):2255-60. 15623683
23. Tanaka-Kagawa T Jinno H Hasegawa T Makino Y Seko Y Hanioka N Ando M Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn) Biochem Biophys Res Commun 2003, 301(2):516-20. 10.1016/ S0006-291X(02)03066-8 12565892
24. Adams HP Jr Bendixen BH Kappelle LJ Biller J Love BB Gordon DL Marsh EE 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 1993, 24(1):35-41. 7678184
25. Kissela B Broderick J Woo D Kothari R Miller R Khoury J Greater Cincinnati/Northern Kentucky Stroke Study: Volume of first-ever ischemic stroke among blacks in a population-based study Stroke 2001, 32(6):1285-1290. 11387488